Work

Abstract PS1-13-23: Survival Results of Phase II Bria-IMT Allogenic Whole Cell-Based Cancer Vaccine

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-13-23

Authors: C. Nangia, S. Chumsri, K. Rowland, L. Negret, J. Knecth, B. Bayer, T. Aghajanian, W. Williams, G. Del Priore, C. Calfa

Institutions: Hoag Memorial Hospital Presbyterian, Mayo Clinic in Florida, University of Miami, Sylvester Comprehensive Cancer Center, Morehouse School of Medicine

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129500020

Cites:

Cited by:

Related to: